47 results
DEFA14A
RLAY
Relay Therapeutics Inc
23 Apr 24
Additional proxy soliciting materials
4:10pm
annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation
8-K
EX-10.1
RLAY
Relay Therapeutics Inc
8 Jan 24
Entry into a Material Definitive Agreement
7:05am
, divorce decree or separation agreement,
(viii) to the Company from an employee of the Company upon death, disability or termination of employment
8-K
EX-99.2
RLAY
Relay Therapeutics Inc
12 Oct 23
Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors
4:13pm
** Including N=2 fusion: 1 patient who discontinued due to death before first post-baseline scan and 1 patient with 1 post-baseline scan that did not meet
8-K
RLAY
Relay Therapeutics Inc
31 May 23
Submission of Matters to a Vote of Security Holders
4:05pm
and qualified, or until his or her earlier death, resignation or removal, with the votes cast as follows:
Name
Votes For
Votes Withheld
Broker Non-Votes
Douglas
DEFA14A
eixooy687jp
21 Apr 23
Additional proxy soliciting materials
4:04pm
8-K
EX-1.1
7lqx4dwkmaf0
15 Sep 22
Relay Therapeutics Announces Proposed Public Offering of Common Stock
6:33am
424B5
n64hzw6rin4ap2gc
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B5
ohbe 31nnpk7yfje9oy5
12 Sep 22
Prospectus supplement for primary offering
7:35am
8-K
2ac 12hnd
27 Jul 22
Departure of Directors or Certain Officers
8:01am
8-K
5fa0h1 27dd
27 May 22
Amendments to Articles of Incorporation or Bylaws
4:37pm
DEFA14A
d4koi yr4kkcklk
14 Apr 22
Additional proxy soliciting materials
4:40pm
PRE 14A
tqc 79jp9el
1 Apr 22
Preliminary proxy
4:30pm
8-K
EX-1.1
4a173z3v sjfz
14 Oct 21
Relay Therapeutics Announces Proposed Public Offering of Common Stock
4:15pm
424B5
0yf22w4d93h38o vqo
13 Oct 21
Prospectus supplement for primary offering
4:32pm
424B5
6w6yz38
12 Oct 21
Prospectus supplement for primary offering
6:50am